Early-onset metabolic syndrome in prepubertal obese children and the possible role of alanine aminotransferase as marker of metabolic syndrome

Annals of Nutrition and Metabolism

Volumn 58, Issue 4, 2011, Pages 307-314

  Calcaterra, V ^a   Muratori, T ^a   Klersy, C ^c   Albertini, R ^b   Caramagna, C ^a   Brizzi, V ^a   Larizza, D ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Laboratory of Clinical Chemistry   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Alanine aminotransferase; Metabolic syndrome; Obesity; Prepubertal children

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN;

ARTICLE; BODY MASS; CHILD; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; ONSET AGE; PREPUBERTY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WEIGHT CONTROL;

AGE OF ONSET; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; EARLY DIAGNOSIS; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; ITALY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE;

EID: 80052592423     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000331573     Document Type: Article

References (66)

1. Aggoun Y: Obesity, metabolic syndrome, and cardiovascular disease. Pediatr Res 2007; 61: 653-659. (Pubitemid 46804930)
2. Gupta A, Gupta V: Metabolic syndrome: what are the risks for humans? Biosci Trends 2010; 4: 204-212.
3. Saland JM: Update on the metabolic syndrome in children. Curr Opin Pediatr 2007; 19: 183-191. (Pubitemid 46668071)
4. Kelishadi R: Childhood overweight, obesity, and the metabolic syndrome in developing countries. Epidemiol Rev 2007; 3: 1-15.
5. Varda NM, Gregoric A: Metabolic syndrome in the pediatric population: a short overview. Pediatr Rev 2009; 1:e1.
6. Arslanian SA, Heil BV, Becker DJ, et al: Sexual dimorphism in insulin sensitivity in adolescents with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1991; 72: 920-926. (Pubitemid 21921786)
7. Moran A, Jacobs DR, Steinberger J, et al: Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999; 48: 2039-2044. (Pubitemid 29458369)
8. Caprio S: Insulin: the other anabolic hormone of puberty. Acta Paediatr 1999; 88: 84-87. (Pubitemid 30007339)
9. Calcaterra V, Klersy C, Muratori T, et al: Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity. Clin Endocrinol 2008; 68: 868-872. (Pubitemid 351703935)
10. Steinberger J, Daniels SR, Eckel RH, American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Council on Nutrition, Physical Activity, and Metabolism: Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009; 119: 628-647.
11. Ekelund U, Anderssen S, Andersen LB, et al: Prevalence and correlates of the metabolic syndrome in a population-based sample of European youth. Am J Clin Nutr 2009; 89: 90-96.
12. Lafortuna CL, Adorni F, Agosti F, et al: Prevalence of the metabolic syndrome among extremely obese adolescents in Italy and Germany. Diabetes Res Clin Pract 2010; 88: 14-21.
13. Druet C, Ong K, Levy Marchal C: Metabolic syndrome in children: comparison of the International Diabetes Federation 2007 consensus with an adapted National Cholesterol Education Program definition in 300 overweight and obese French children. Horm Res Paediatr 2010; 73: 181-186.
14. Valle M, Gascón F, Martos R, et al: Metabolic cardiovascular syndrome in obese prepubertal children: the role of high fasting insulin levels. Metabolism 2002; 51: 423-428. (Pubitemid 34406555)
15. D'Adamo E, Marcovecchio ML, Giannini C, et al: The possible role of liver steatosis in defining metabolic syndrome in prepubertal children. Metabolism 2010; 59: 671-676.
16. Louzada Strufaldi ML, Koga Da Silva ED, Fiorini Puccini R: Metabolic syndrome among prepubertal Brazilian schoolchildren. Diabetes Vasc Dis Res 2008; 4: 294-297.
17. Braunschweig CL, Gomez S, Liang H, et al: Obesity and risk factors for the metabolic syndrome among low-income, urban African-American schoolchildren: the rule rather than the exception? Am J Clin Nutr 2005; 81: 970-975. (Pubitemid 41724935)
18. Zimmet P, Alberti KG, Kaufman F, et al: The metabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes 2007; 8: 299-306. (Pubitemid 47422902)
19. Takahashi Y, Fukusato T: Pediatric non-alcoholic fatty liver disease: overview with emphasis on histology. World J Gastroenterol 2010; 16: 5280-5285.
20. Adams LA, Feldstein AE: Nonalcoholic steatohepatitis: risk factors and diagnosis. Expert Rev Gastroenterol Hepatol 2010; 4: 623-635.
21. Brunt E: Pathology of nonalcaholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2010; 7: 195-203.
22. Abe Y, Kikuchi T, Nagasaki K, et al: Usefulness of GPT for diagnosis of metabolic syndrome in obese Japanese children. J Atheroscler Thromb 2009; 16: 902-909.
23. Cacciari E, Milani S, Balsamo A, et al: Italian cross-sectional growth charts for height, weight and BMI (2-20 years). J Endocrinol Invest 2006; 29: 581-593. (Pubitemid 44446267)
24. Marshall WA, Tanner JM: Variations in patterns of pubertal changes in boys. Arch Dis Child 1969; 45: 13-23.
25. Marshall WA, Tanner JM: Variations in patterns of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
27. Maffeis C, Pietrobelli A, Salvatoni A, et al: Obesità del bambino e dell'adolescente: consensus su prevenzione, diagnosi e terapia; in Salari P (ed): Argomenti di Pediatria 1/06. Milano, Istituto Scotti Bassani, 2006, pp 31.
28. d'Annunzio G, Vanelli M, Pistorio A, et al: Insulin resistance and secretion indexes in healthy Italian children and adolescents: a multicentre study. Acta Biomedica 2009; 80: 21-28.
29. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1999; 22(suppl 1):S5-S19.
30. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555-576.
31. Third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in adults (adult treatment panel III). Bethesda, National Heart, Lung, and Blood Institute, 2001.
32. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus provision-al report of a WHO consultation. Diabet Med 1998; 15: 539-553. (Pubitemid 28319935)
33. Franks PW, Hanson RL, Knowler WC, et al: Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 2010; 362: 485-493.
34. van Vliet M, Gazendam RP, von Rosenstiel IA, et al: Differential impact of impaired fasting glucose versus impaired glucose tolerance on cardiometabolic risk factors in multi-ethnic overweight/obese children. Eur J Pediatr 2010;170:589-597.
35. Schwartz B, Jacobs DR, Moran A, et al: Measurement of insulin sensitivity in children: comparison between the euglycemic hyperinsulinemic clump and surrogate measures. Diabetes Care 2008; 31: 783-788.
36. Goesslin W, Massaro JM, Vasan RS, et al: Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 2008; 135: 1935-1944.
37. Gairdner D, Pearson J: A growth chart for premature and other infants. Arch Dis Child 1971; 46: 783-787.
38. Ode KL, Frobnert BI, Nathan BM: Identification and treatment of metabolic complications in pediatric obesity. Rev Endocr Metab Disord 2009; 10: 167-188.
39. Bitsori M, Kafatos A: Dysmetabolic syndrome in childhood and adolescence. Acta Paediatr 2005; 94: 995-1005. (Pubitemid 41169643)
40. Csábi G, Török K, Jeges S, et al: Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr 2000; 159: 91-94. (Pubitemid 30120135)
41. Srinivasan SR, Myers L, Berenson GS: Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study. Diabetes 2002; 51: 204-209. (Pubitemid 34517999)
42. Lee S, Bacha F, Gungor N, Arslanian S: Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. J Pediatr 2008; 152: 177-184.
43. Druet C, Dabbas M, Baltakse V, et al: Insulin resistance and the metabolic syndrome in obese French children. Clin Endocrinol 2006; 64: 672-678. (Pubitemid 43775006)
44. Lopez-Capape M, Alonso M, Colino E, et al: Frequency of the metabolic syndrome in obese Spanish pediatric population. Eur J Endocrinol 2006; 155: 313-319. (Pubitemid 44269449)
45. Cook S, Weitzman M, Auinger P, et al: Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003; 157: 821-827. (Pubitemid 36988016)
46. Hales CN, Barker DJ, Clark PM, et al: Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991; 303: 1019-1022.
47. Hattersley AT, Tooke JE: The fetal insulin hypothesis: an alternative explanation of the association of low birth weight with diabetes and vascular disease. Lancet 1999; 353: 1789-1792. (Pubitemid 29240389)
48. Barker DJ, Gluckman PD, Godfrey KM, et al: Fetal nutrition and cardiovascular disease in adult life. Lancet 1993; 341: 938-941. (Pubitemid 23109122)
49. Hales CN, Barker DJ: The thrifty phenotype hypothesis. Br Med Bull 2001; 60: 5-20. (Pubitemid 34123501)
50. Bruce KD, Hanson MA: The developmental origins, mechanisms, and implications of metabolic syndrome. J Nutr 2010; 140: 648-652.
51. Juarez-Lopez C, Klunder-Klunder M, Medina-Bravo P, et al: Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents. BMC Public Health 2010; 10: 318.
52. Sinaiko A, Steinberger J, Moran A, et al: Relation of insulin resistance to blood pressure in childhood. J Hypertens 2002; 20: 509-517. (Pubitemid 34913751)
53. Reaven G, Abbasi F, McLaughlin T: Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res 2004; 59: 207-223. (Pubitemid 41327152)
54. Rademacher ER, Jacobs DR Jr, Moran A, et al: Relation of blood pressure and body mass index during childhood to cardiovascular risk factor levels in young adults. J Hypertens 2009; 27: 1766-1774.
55. McNiece KL, Poffenbarger TS, Turnerm JL, et al: Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr 2007; 150: 640-644.
56. Egan BM, Green EL, Goodfriend TL: Insulin resistance and cardiovascular disease. Am J Hypertens 2001; 14: 116S-125S. (Pubitemid 32506705)
57. Sorof J, Daniels S: Obesity hypertension in children: a problem of epidemic proportions. Hypertension 2002; 40: 441-447.
58. Morales PA, Mitchell BD, Valdez RA, et al: Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study. Diabetes 1993; 42: 154-161. (Pubitemid 23013808)
59. Manlhiot C, Larsson P, Gurofsky RC, et al: Spectrum and management of hypertriglyceridemia among children in clinical practice. Pediatrics 2009; 123: 458-465.
60. Reddy KJ, Singh M, Bangit JR, et al: The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review. J Cardiovasc Med 2010; 11: 633-647.
61. Gonzàles-Gil EM, Bueno-Lozano G, Bueno-Lozano O, et al: Serum transaminase concentrations in obese children and adolescents. J Physiol Biochem 2009; 65: 51-60.
62. Engiz O, Berberoglu M, Siklar S, et al: Risk factor for non-alcoholic fatty liver disease in obese children. Horm Res 2009; 72: 63-64.
63. Burgert TS, Taksali SE, Dziura J, et al: Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006; 91: 4287-4294. (Pubitemid 44833400)
64. Fracanzani AL, Valenti L, Bugianesi E, et al: Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 2008; 48: 792-798.
65. Kelishadi R, Cook SR, Adibi A, et al: Association of the components of the metabolic syndrome with non-alcoholic fatty liver disease among normal-weight, overweight and obese children and adolescents. Diabetol Metab Syndr 2009; 1: 29.
66. D'Adamo E, Cali AM, Weiss R, et al: Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 2010; 33: 1817-1822.